Delmar, NY, United States of America

David John Fairfax


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David John Fairfax

Introduction

David John Fairfax is a notable inventor based in Delmar, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Fairfax has made strides in developing innovative compounds and processes that have the potential to impact medical treatments.

Latest Patents

Among his latest patents, one focuses on PARP inhibitors. This invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, along with compositions and methods for their production and use. The patent details compounds of a specific formula, including pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. Another patent involves a process for preparing piperazine-substituted aliphatic carboxylates, which outlines a method for synthesizing these compounds with a defined formula.

Career Highlights

Throughout his career, David John Fairfax has worked with several prominent companies, including Salsbury Chemicals, Inc. and Icos Corporation. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and has facilitated his innovative work.

Collaborations

Fairfax has collaborated with notable colleagues such as Erik T Michalson and Graham Beaton. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

David John Fairfax exemplifies the spirit of innovation in the pharmaceutical field through his patents and collaborations. His work continues to pave the way for advancements in medical treatments and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…